Loading insider details...
Latest Form 4 (Aug 6, 2026): Exercise/Conversion of 50,366 IMNM shares, $650.7K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 6, 2026 | Immunome Inc. (IMNM) | Exercise/Conversion | 50,366 | $650.7K |
| Jul 27, 2026 | Immunome Inc. (IMNM) | Grant/Award | 31,250 | n/a |
| Jul 9, 2026 | Immunome Inc. (IMNM) | Exercise/Conversion | 1,092 | $14.1K |
| Jul 31, 2025 | Immunome Inc. (IMNM) | Grant/Award | 161,000 | n/a |
| Aug 13, 2024 | Immunome Inc. (IMNM) | Grant/Award | 130,000 | n/a |
| Feb 22, 2024 | Immunome Inc. (IMNM) | Grant/Award | 300,000 | n/a |
| Feb 2, 2023 | Olema Pharmaceuticals, Inc. (OLMA) | Grant/Award | 150,000 | n/a |
| Mar 14, 2022 | Olema Pharmaceuticals, Inc. (OLMA) | Exercise/Conversion | 5,253 | $10.8K |
| Feb 14, 2022 | Olema Pharmaceuticals, Inc. (OLMA) | Exercise/Conversion | 5,251 | $10.8K |
| Feb 4, 2022 | Olema Pharmaceuticals, Inc. (OLMA) | Grant/Award | 133,000 | n/a |